This paper is in the following e-collection/theme issue:

Randomized trials (Editor: G. Eysenbach)* (34) Tx to JMIR Diabetes awaiting author consent (1) Tx to JMIR Formative Res awaiting author consent (1)

Published on in Vol 26 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53740, first published .
Efficacy of Save Medical Corporation (SMC)–01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial

Efficacy of Save Medical Corporation (SMC)–01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial

Efficacy of Save Medical Corporation (SMC)–01, a Smartphone App Designed to Support Type 2 Diabetes Self-Management Based on Established Guidelines: Randomized Controlled Trial

Authors of this article:

Nicholas Leung1 Author Orcid Image ;   Kayo Waki2, 3, 4 Author Orcid Image ;   Satoshi Nozoe5 Author Orcid Image ;   Shunpei Enomoto2 Author Orcid Image ;   Ryo Saito2 Author Orcid Image ;   Sakurako Hamagami6 Author Orcid Image ;   Toshimasa Yamauchi4 Author Orcid Image ;   Masaomi Nangaku7 Author Orcid Image ;   Kazuhiko Ohe2, 3 Author Orcid Image ;   Yukiko Onishi8 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.